The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: A qualitative report
MetadataShow full item record
Background: In Australia, temporary visa holders are ineligible for Medicare and subsidised antiretroviral drugs. Additionally, HIV testing is not mandatory for visas unless applicants seek work in the health sector. We sought to understand the impact of HIV and issues of access and adherence to antiretroviral therapy (ART) in people holding temporary visas and permanent residents. Methods: Data were gathered from interviews with 22 participants. Information concerning medication adherence, side effects, CD4 T-cell count, viral load and rate of response to generic drugs were collected. Results: The mean age was 33.4 years (±s.d. = 6.0), 21 out of 22 were from HIV-prevalent areas in East Africa and Asia, 14 out of 22 were on temporary visas, 12 were ineligible for Medicare, 14 out of 22 were diagnosed during health screening, 19 out of 22 risk exposures were in country of origin, 8 out of 17 were taking generic ART at an average cost of $180 per month, adherence was excellent and self-reported side-effects were relatively infrequent. Participants applying for visa continuations and permanent residency were fearful, believing their HIV serostatus would prejudice their applications. Patients cited belief in ART efficacy, were motivated to maintain therapy and were anxious about lack of access to treatment in their countries of origin. Conclusion: Adherence to antiretroviral drugs in Medicare-ineligible HIV-infected individuals is excellent despite limited access to treatment. The threat of visa non-renewal and the likely failure of applications for permanent residency result in considerable anxiety and confidentiality concerns.
Showing items related by title, author, creator and subject.
Goede, S.; Kuntz, K.; Van Ballegooijen, M.; Knudsen, A.; Lansdorp_Vogelaar, Iris; Tangka, F.; Howard, D.; Chin, J.; Zauber, A.; Seeff, L. (2015)Background: Many individuals have not received recommended colorectal cancer (CRC) screening before they become Medicare eligible at the age of 65. We aimed to estimate the long-term implications of increased CRC screening ...
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular diseaseAngell, B.; Laba, T.; Lung, T.; Brown, A.; Eades, S.; Usherwood, T.; Peiris, D.; Billot, L.; Hillis, G.; Webster, R.; Tonkin, A.; Reid, Christopher; Molanus, B.; Rafter, N.; Cass, A.; Patel, A.; Jan, S. (2017)Background: In spite of bearing a heavier burden of death, disease and disability, there is mixed evidence as to whether Indigenous Australians utilise more or less healthcare services than other Australians given their ...
Lansdorp_Vogelaar, Iris; Fedewa, S.; Lin, C.; Virgo, K.; Jemal, A. (2014)Background: Surveillance in patients with previous polypectomy was underused in the Medicare population in 1994. This study investigates whether expansion of Medicare reimbursement for colonoscopy screening in high-risk ...